Ulcerative Colitis

A chronic inflammatory bowel disease characterized by continuous mucosal inflammation of the colon, extending proximally from the rectum. Unlike crohns disease, UC is limited to the colon, affects only the mucosa/submucosa (not transmural), produces no skip lesions, and has no granulomas. From a metallomics perspective, UC presents a distinct metal signature from Crohn's, driven by chronic blood loss, mucosal inflammation, and a microbiome collapse that differs in character from the Crohn's pattern.

Metallomic Signature

Iron -- The Bleeding Metal

Iron deficiency is the dominant metal abnormality in UC, driven by chronic mucosal bleeding:

  • Prevalence: 60-80% of active UC patients have iron deficiency; 30-40% have frank anemia
  • Mechanism: Chronic blood loss from ulcerated mucosa + hepcidin elevation from inflammation → functional iron deficiency even with adequate stores
  • The iron paradox: Oral iron supplementation worsens UC by feeding iron-dependent pathobionts (E. coli, Klebsiella), increasing oxidative stress in the inflamed mucosa, and shifting the microbiome toward dysbiosis. IV iron bypasses the gut but still raises hepcidin.
  • Ferritin is unreliable as an iron marker in UC (acute phase reactant; elevated by inflammation)

Copper -- Elevated in Active Disease

  • Serum copper and ceruloplasmin rise during UC flares (acute phase response)
  • Tissue copper may be depleted despite elevated serum levels
  • Cu/Zn ratio is elevated and correlates with disease activity
  • Ceruloplasmin's ferroxidase activity links copper to iron handling

Zinc -- Depleted and Protective

  • Serum zinc is consistently low in active UC
  • Zinc deficiency impairs mucosal healing, reduces tight junction integrity, and weakens antimicrobial peptide (defensin) production
  • Zinc supplementation in UC improves barrier function and reduces relapse in small trials
  • ZIP8 transporter polymorphism (A391T) alters zinc handling in the gut — see crohns disease for the genetics

Selenium -- Deficient with Consequences

  • Selenium deficiency is common in UC and correlates with disease severity
  • Se is required for glutathione peroxidase (antioxidant defense in inflamed mucosa)
  • Se deficiency impairs Treg function (see immune balance), potentially perpetuating the autoimmune component

Microbiome in UC

UC has a characteristic dysbiotic signature:

Depleted Taxa

  • Faecalibacterium prausnitzii — the most consistently depleted taxon in UC; produces butyrate, has direct anti-inflammatory effects (IL-10 induction); its absence is a hallmark of active disease
  • Roseburia — another major butyrate producer lost in UC
  • Bacteroides — reduced diversity within this genus
  • Overall diversity — alpha diversity reduced, particularly during flares

Enriched Taxa

  • Escherichia coli — especially adherent-invasive E. coli (AIEC); enriched in inflamed mucosa; high iron requirement fuels expansion when mucosal bleeding provides iron
  • Enterococcus — expands in the depleted ecosystem
  • Fusobacterium — associated with colorectal neoplasia in longstanding UC
  • Ruminococcus gnavus — mucin degrader enriched in UC flares

Metabolic Consequences

  • short chain fatty acids (especially butyrate) are profoundly reduced in UC
  • Butyrate is the primary fuel for colonocytes — its depletion creates an energy crisis in the epithelium
  • Reduced SCFA → weakened barrier function → increased translocation → more inflammation → a vicious cycle
  • Bile acid metabolism is altered (reduced secondary bile acids from microbial deconjugation)

Distinguishing UC from Crohn's: The Metallomic View

FeatureUlcerative Colitiscrohns disease
Iron deficiencyDominant (bleeding)Present (malabsorption)
CopperElevated (acute phase)Variable
ZincDepletedDepleted + ZIP8 genetic link
SeleniumDepletedDepleted
calprotectinVery high (>250 mcg/g in active)High but more variable
Key depleted taxaF. prausnitzii, RoseburiaF. prausnitzii + broader loss
Key enriched taxaE. coli, EnterococcusAIEC, Ruminococcus gnavus
FMT evidenceStronger (multiple positive RCTs)Weaker (case series)

Fecal Microbiota Transplantation (FMT)

UC has the strongest FMT evidence of any IBD subtype:

  • Multiple RCTs show clinical remission in 25-35% of UC patients (vs. 5-10% placebo)
  • Donor microbiome diversity predicts response — donors with high Lachnospiraceae and Ruminococcaceae abundance produce better outcomes
  • FMT restores butyrate production and F. prausnitzii populations
  • Metal implications: FMT may normalize the metal-handling capacity of the microbiome (metal-binding, biotransformation), though this is unstudied

The Iron-Pathobiont Feedback Loop

A UC-specific vicious cycle:

  1. Mucosal ulceration → bleeding → luminal iron excess
  2. Luminal iron feeds iron-dependent E. coli and Enterobacteriaceae
  3. Pathobiont expansion → more inflammation → more tissue damage
  4. More bleeding → more luminal iron → cycle accelerates
  5. Simultaneously, systemic iron deficiency worsens (blood loss outpaces absorption)

This explains why oral iron is generally avoided during active UC flares and why iron-restricted pathobiont control is a recognized research target.

<!— Intervention/treatment content moved to Cureva per public/clinical boundary policy —>

Key Sources

Connections

  • inflammatory bowel disease — the parent category; UC is the mucosal-limited colonic subtype
  • crohns disease — the key differential; distinct metal signature and microbiome pattern
  • iron — dominant metal abnormality; chronic mucosal bleeding drives deficiency; oral iron feeds pathobionts
  • zinc — depleted in active UC; supplementation improves barrier function and reduces relapse
  • copper — elevated serum Cu during flares (acute phase response); Cu/Zn ratio tracks disease activity
  • selenium — deficiency common and correlates with severity; required for antioxidant defense
  • calprotectin — primary non-invasive biomarker; very high (>250 mcg/g) in active disease
  • dysbiosis — F. prausnitzii and Roseburia depletion; E. coli and Enterococcus enrichment
  • short chain fatty acids — profound butyrate reduction creates colonocyte energy crisis
  • intestinal permeability — barrier dysfunction central to the inflammation-translocation vicious cycle
  • immune balance — Th17/Treg imbalance perpetuates mucosal inflammation
  • fecal microbiota transplant — strongest FMT evidence of any IBD subtype; 25-35% clinical remission
  • probiotics — VSL#3 for maintaining remission; E. coli Nissle 1917 efficacy comparable to mesalazine
  • pharmacomicrobiomics — bacterial azoreductases convert sulfasalazine to active 5-ASA

References (6)

  1. Amerikanou C, Karavoltsos S, Gioxari A et al. (2022). Clinical and inflammatory biomarkers of inflammatory bowel diseases are linked to plasma trace elements and toxic metals; new insights into an old concept. Frontiers in Nutrition. doi:10.3389/fnut.2022.997356
  2. ★Yang JC, Zhao M, Chernikova D et al. (2024). ZIP8 A391T Crohn's Disease-Linked Risk Variant Induces Colonic Metal Ion Dyshomeostasis, Microbiome Compositional Shifts, and Inflammation. Digestive Diseases and Sciences. doi:10.3389/fimmu.2023.1183914
  3. ★Sweta Ghosh, Syam P. Nukavarpu, Venkatakrishna Rao Jala (2023). Effect of Heavy Metals on Gut Barrier Integrity and Gut Microbiota. Metal ions in Life Sciences (Accepted Manuscript)
  4. M. Firoze Khan, Hui Wang (2020). Environmental Exposures and Autoimmune Diseases: Contribution of Gut Microbiome. Frontiers in Immunology. doi:10.3389/fimmu.2019.03094
  5. ★Federica Giambo, Sebastiano Italia, Michele Teodoro et al. (2021). Influence of Toxic Metal Exposure on the Gut Microbiota (Review). World Academy of Sciences Journal
  6. ★Qinheng Zhu, Boyan Chen, Fu Zhang et al. (2024). Toxic and Essential Metals: Metabolic Interactions with the Gut Microbiota and Health Implications. Frontiers in Nutrition. doi:10.1016/j.biopha.2023.115602

Related Articles